PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 215 filers reported holding PDL BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $29,355,000 | +5.0% | 9,318,552 | -3.0% | 0.01% | 0.0% |
| Q2 2020 | $27,946,000 | +3.0% | 9,603,719 | -0.2% | 0.01% | -14.3% |
| Q1 2020 | $27,131,000 | -12.3% | 9,621,059 | +0.9% | 0.01% | +27.3% |
| Q4 2019 | $30,928,000 | +40.2% | 9,530,949 | -6.7% | 0.01% | +22.2% |
| Q3 2019 | $22,059,000 | -36.4% | 10,212,232 | -7.6% | 0.01% | -30.8% |
| Q2 2019 | $34,688,000 | -22.6% | 11,047,261 | -8.3% | 0.01% | -27.8% |
| Q1 2019 | $44,802,000 | +24.1% | 12,043,406 | -3.3% | 0.02% | +12.5% |
| Q4 2018 | $36,113,000 | +8.9% | 12,453,121 | -1.3% | 0.02% | +23.1% |
| Q3 2018 | $33,173,000 | +13.3% | 12,613,444 | +0.8% | 0.01% | +8.3% |
| Q2 2018 | $29,284,000 | -13.5% | 12,514,490 | +8.7% | 0.01% | -14.3% |
| Q1 2018 | $33,862,000 | +19.0% | 11,517,800 | +10.9% | 0.01% | +16.7% |
| Q4 2017 | $28,465,000 | -3.6% | 10,388,372 | +19.3% | 0.01% | -7.7% |
| Q3 2017 | $29,518,000 | +60.9% | 8,707,461 | +17.2% | 0.01% | +62.5% |
| Q2 2017 | $18,348,000 | +42.2% | 7,428,030 | +30.7% | 0.01% | +33.3% |
| Q1 2017 | $12,901,000 | +42.1% | 5,683,650 | +32.7% | 0.01% | +20.0% |
| Q4 2016 | $9,078,000 | -26.8% | 4,282,180 | +15.7% | 0.01% | -28.6% |
| Q3 2016 | $12,394,000 | +7.3% | 3,699,915 | +0.6% | 0.01% | 0.0% |
| Q2 2016 | $11,553,000 | +5.8% | 3,679,215 | +12.2% | 0.01% | 0.0% |
| Q1 2016 | $10,916,000 | +6.6% | 3,278,389 | +13.4% | 0.01% | +16.7% |
| Q4 2015 | $10,237,000 | -26.0% | 2,891,641 | +5.1% | 0.01% | -33.3% |
| Q3 2015 | $13,839,000 | -21.9% | 2,751,402 | -0.1% | 0.01% | -18.2% |
| Q2 2015 | $17,711,000 | -6.4% | 2,754,502 | +2.4% | 0.01% | -8.3% |
| Q1 2015 | $18,930,000 | -8.8% | 2,690,741 | -0.0% | 0.01% | -14.3% |
| Q4 2014 | $20,747,000 | +2.2% | 2,690,941 | -1.0% | 0.01% | 0.0% |
| Q3 2014 | $20,295,000 | -22.8% | 2,716,799 | +0.1% | 0.01% | -22.2% |
| Q2 2014 | $26,272,000 | +16.1% | 2,714,023 | -0.3% | 0.02% | +5.9% |
| Q1 2014 | $22,621,000 | -2.6% | 2,722,123 | -1.1% | 0.02% | -5.6% |
| Q4 2013 | $23,224,000 | +2.8% | 2,751,695 | -3.0% | 0.02% | -10.0% |
| Q3 2013 | $22,602,000 | +2.8% | 2,835,691 | -0.5% | 0.02% | -4.8% |
| Q2 2013 | $21,997,000 | – | 2,849,419 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |